Stifel Nicolaus lowered shares of Innocoll Holdings PLC (NDAQ:INNL) from a buy rating to a hold rating in a research note published on Friday. Stifel Nicolaus currently has $2.00 price target on the stock.
Shares of Innocoll Holdings PLC (NDAQ:INNL) traded down 11.20% on Friday, reaching $1.11. The company’s stock had a trading volume of 3,936,805 shares. The stock’s market capitalization is $32.97 million. Innocoll Holdings PLC has a 1-year low of $0.53 and a 1-year high of $12.94. The company has a 50 day moving average of $0.78 and a 200 day moving average of $2.97.
Your IP Address:
About Innocoll Holdings PLC
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
Receive News & Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.